Why Is Joseph Edelman’s Hedge Fund So Bullish On AcelRx?

In a disclosure of its holdings, Joseph Edelman's Perceptive Advisors made public that it currently owns 6.57 million shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) last week...

Keep Reading →